Digital Ophthalmology | Ophthalmology Innovation Source

MDbackline

MDbackline has developed a cloud-based, secure, online software that automates physician contact with patients outside of the office and can work with any electronic health records (EHR) system, founder John Hovanesian, MD, reported at OIS@AAO 2015. The system allows patients to submit questions to doctors electronically via tablet, phone or computer, allows doctors to provide…

ALPHAEON

In the world of self-pay physician services, connecting patients and providers on a broad scale has been difficult, but with the introduction of its ShoutMD platform and the launch of a direct-to-consumer ad campaign, Alphaeon Corp. is creating what CEO Robert E. Grant called “a whole ecosystem” that aims to do that and more for…

Digital Ophthalmology Sector Overview

Participant: Michelle Snyder Michelle is currently the CMO at Welltok leading all corporate and product marketing efforts and is an investment and operational advisor to InterWest Partners. View Full Profile

Ophthalmic Innovation 2015 – “A View from the AAO”

Participant: David Parke, MD II Dr. Parke is CEO of the American Academy of Ophthalmology. Prior to assuming this role, Dr. Parke served as president and CEO of the Dean McGee Eye Institute and Chair of the Department of Ophthalmology at the University of Oklahoma. View Full Profile

LacriScience

LacriScience is in late stage development of its LacriPen, a portable instrument using gold plated single-use sensors that measures osmolarity to +/- 2 mOSM/L and proteins. By coating the gold film with a specific antibody, such as Adenovirus, Herpes Zoster, Herpes Simplex, or any biomaker, it can be precisely identified or quantified instantly. www.lacripen.com Participant:…

A Record-Setting OIS

Last week’s Ophthalmology Innovation Summit drew nearly 1,000 attendees to Las Vegas’ Planet Hollywood hotel, marking the largest OIS event we’ve held yet. The size of the audience only added to the energy of what’s becoming a kickoff tradition for the American Academy of Ophthalmology’s annual meeting. Three dozen ophthalmology companies – representing Drug Delivery,…

Biggest OIS Ever Set to Deliver News & Insights

The maturation and advance of the ophthalmology sector will be fully evident tomorrow as we host the largest Ophthalmology Innovation Summit in its seven-year history. More than 900 clinicians, investors, and executives will descend upon the Planet Hollywood Hotel in Las Vegas to grab a glimpse of novel new treatments for ophthalmology disorders. Three dozen…

Implandata’s Hands-On Approach To Tracking IOP

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 059″] Implandata Ophthalmic Products GmbH is putting the task of tracking intraocular pressure into the hands of patients. Company Co-Founder and General Manager Max G. Ostermeier shares the story of EyeMate, an implantable micro sensor capable of measuring absolute intraocular pressure continuously or on demand. Podcast Guest Max G. Ostermeier, MBA…

Google Lens Clinical Trials to Start in 2016

Novartis, through its Alcon eye-care division, intends to start clinical trials of an accommodative Google “smart” contact lens in human eyes next year, Novartis Chief Executive Joe Jimenez told the Swiss French-language newspaper Le Temps last week. “This project is progressing well,” Jimenez told Le Temps reporter Willy Boder. “When we announced the agreement a…

LacriScience

The company’s LacriPen is a handheld, portable, diagnostic tool that measures osmolarity to within 2 mOsml. It uses a technique called surface plasma residence, which calculates minute changes in the refractive index on a very thin gold film. The reflectivity minimum line produces moves as a measure of osmolarity; when in use the device is…

Blumenkranz Shares His Success, Failures And New Opportunities For Ophthalmic Innovators

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 029″] Mark Blumenkranz, MD, has had a hand in starting many exciting biotech, medtech and digital health companies. Hear how his innovative process begins and what he’s doing to help foster new ideas in ophthalmology. Podcast Guest Mark S. Blumenkranz, MD Mark S. Blumenkranz, MD, MMS, is HJ Smead Professor in…

DigiSight Puts Eye Care in Patients’ Hands

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 025″] DigiSight President and CEO Doug Foster explains how mobile technologies like his company’s SightBook app can help save patient vision and help the pharmaceutical industry develop new ophthalmology drugs. Podcast Guest Doug Foster Doug Foster is CEO of DigiSight Technologies. He has over 15 years experience identifying and developing technologies…